165 related articles for article (PubMed ID: 37671793)
41. 7: Soft tissue, bone and joint infections.
Gottlieb T; Atkins BL; Shaw DR
Med J Aust; 2002 Jun; 176(12):609-15. PubMed ID: 12064963
[TBL] [Abstract][Full Text] [Related]
42. Management of bone and joint infections due to Staphylococcus aureus.
Davis JS
Intern Med J; 2005 Dec; 35 Suppl 2():S79-96. PubMed ID: 16271064
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study.
Courjon J; Demonchy E; Cua E; Bernard E; Roger PM
Eur J Clin Microbiol Infect Dis; 2017 Dec; 36(12):2513-2518. PubMed ID: 28884303
[TBL] [Abstract][Full Text] [Related]
44. Treatment options for diabetic foot osteomyelitis.
Senneville E; Robineau O
Expert Opin Pharmacother; 2017 Jun; 18(8):759-765. PubMed ID: 28406331
[TBL] [Abstract][Full Text] [Related]
45. Pediatric bone and joint infections. Diagnosis and antimicrobial management.
Sonnen GM; Henry NK
Pediatr Clin North Am; 1996 Aug; 43(4):933-47. PubMed ID: 8692588
[TBL] [Abstract][Full Text] [Related]
46. [Local antibiotic therapy of bone, joint and soft tissue infections].
Lob G
Chirurg; 1985 Sep; 56(9):564-7. PubMed ID: 4053764
[No Abstract] [Full Text] [Related]
47. Native bone and joint infections caused by extended-spectrum β-lactamase-producing Enterobacterales: experience of a reference centre in the Greater Paris area.
Davido B; Saleh-Mghir A; Rottman M; Jaffal K; Salomon E; Bouchand F; Lawrence C; Bauer T; Herrmann JL; De Truchis P; Noussair L; Cremieux AC
Int J Antimicrob Agents; 2022 Jan; 59(1):106497. PubMed ID: 34906675
[TBL] [Abstract][Full Text] [Related]
48. The CRIOAc healthcare network in France: A nationwide Health Ministry program to improve the management of bone and joint infection.
Ferry T; Seng P; Mainard D; Jenny JY; Laurent F; Senneville E; Grare M; Jolivet-Gougeon A; Bernard L; Marmor S;
Orthop Traumatol Surg Res; 2019 Feb; 105(1):185-190. PubMed ID: 30413338
[TBL] [Abstract][Full Text] [Related]
49. Treating osteomyelitis: antibiotics and surgery.
Rao N; Ziran BH; Lipsky BA
Plast Reconstr Surg; 2011 Jan; 127 Suppl 1():177S-187S. PubMed ID: 21200289
[TBL] [Abstract][Full Text] [Related]
50. Early switch from intravenous to oral antibiotic treatment in bone and joint infections.
Sendi P; Lora-Tamayo J; Cortes-Penfield NW; Uçkay I
Clin Microbiol Infect; 2023 Sep; 29(9):1133-1138. PubMed ID: 37182643
[TBL] [Abstract][Full Text] [Related]
51. Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections.
Bassetti M; Pecori D; Cojutti P; Righi E; Pea F
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1193-1200. PubMed ID: 28988505
[TBL] [Abstract][Full Text] [Related]
52. [Treatment of bone and periprosthetic infections with bacteriophages : A systematic review].
Walter N; Deng L; Brochhausen C; Alt V; Rupp M
Orthopade; 2022 Feb; 51(2):138-145. PubMed ID: 34499212
[TBL] [Abstract][Full Text] [Related]
53. Cefotaxime therapy for patients with osteomyelitis and septic arthritis.
Mader JT; LeFrock JL; Hyams KC; Molavi A; Reinarz JA
Rev Infect Dis; 1982; 4 Suppl():S472-80. PubMed ID: 6294801
[TBL] [Abstract][Full Text] [Related]
54. The application of ceragenins to orthopedic surgery and medicine.
Dao A; Mills RJ; Kamble S; Savage PB; Little DG; Schindeler A
J Orthop Res; 2020 Sep; 38(9):1883-1894. PubMed ID: 31994754
[TBL] [Abstract][Full Text] [Related]
55. Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.
Senneville E; Nguyen S
Expert Opin Pharmacother; 2013 Apr; 14(6):723-34. PubMed ID: 23496344
[TBL] [Abstract][Full Text] [Related]
56. [Hematogenous bone and joint infections in children].
Sacher P; Meuli M
Ther Umsch; 1990 Jul; 47(7):574-85. PubMed ID: 2202076
[TBL] [Abstract][Full Text] [Related]
57. Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014-17).
Carvalhaes CG; Sader HS; Flamm RK; Mendes RE
J Antimicrob Chemother; 2019 Jul; 74(7):1928-1933. PubMed ID: 30932152
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of oral fleroxacin in bone and joint infections.
Green SL
Am J Med; 1993 Mar; 94(3A):174S-176S. PubMed ID: 8452176
[TBL] [Abstract][Full Text] [Related]
59. Impact of antibiotic pretreatment on cultures in children with osteomyelitis and septic arthritis: a retrospective review.
Lansell A; Vasili Y; Suchdev PS; Figueroa J; Kirpalani A
BMC Pediatr; 2021 Aug; 21(1):342. PubMed ID: 34389010
[TBL] [Abstract][Full Text] [Related]
60. [Management of bone and joint infections: update].
Barroco C; Meyssonnier V; Suva D; Pham TT
Rev Med Suisse; 2023 Apr; 19(822):714-718. PubMed ID: 37057852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
